How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How to Use a Chemotherapeutic Agent When Resistance to It Threatens the Patient
Authors
Keywords
Cancer treatment, Pathogens, Drug therapy, Population density, Antimicrobial resistance, Aggressive chemotherapy, Immunity, Chemotherapy
Journal
PLOS BIOLOGY
Volume 15, Issue 2, Pages e2001110
Publisher
Public Library of Science (PLoS)
Online
2017-02-10
DOI
10.1371/journal.pbio.2001110
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With RecurrentClostridium difficileInfection
- (2016) Braden Millan et al. CLINICAL INFECTIOUS DISEASES
- Roots and routes of resistance
- (2016) Anish Thomas Science Translational Medicine
- Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer
- (2016) Pedro M. Enriquez-Navas et al. Science Translational Medicine
- Integrating Antimicrobial Therapy with Host Immunity to Fight Drug-Resistant Infections: Classical vs. Adaptive Treatment
- (2016) Erida Gjini et al. PLoS Computational Biology
- Does High-Dose Antimicrobial Chemotherapy Prevent the Evolution of Resistance?
- (2016) Troy Day et al. PLoS Computational Biology
- How I treat high-risk myeloma
- (2015) S. Lonial et al. BLOOD
- Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract
- (2015) Sushma Kommineni et al. NATURE
- Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms
- (2015) Diarmaid Hughes et al. NATURE REVIEWS GENETICS
- Assessment of ABT-263 activity across a cancer cell line collection leads to a potent combination therapy for small-cell lung cancer
- (2015) Anthony C. Faber et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The value of monitoring to control evolving populations
- (2015) Andrej Fischer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Imperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance
- (2015) Stefany Moreno-Gamez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting copper to treat breast cancer
- (2015) K. Garber SCIENCE
- A small-molecule antivirulence agent for treating Clostridium difficile infection
- (2015) Kristina Oresic Bender et al. Science Translational Medicine
- Applying Pharmacokinetic/Pharmacodynamic Principles in Critically Ill Patients: Optimizing Efficacy and Reducing Resistance Development
- (2015) Mohd Abdul-Aziz et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Engineering Microbiomes to Improve Plant and Animal Health
- (2015) U.G. Mueller et al. TRENDS IN MICROBIOLOGY
- Is selection relevant in the evolutionary emergence of drug resistance?
- (2015) Troy Day et al. TRENDS IN MICROBIOLOGY
- How competition governs whether moderate or aggressive treatment minimizes antibiotic resistance
- (2015) Caroline Colijn et al. eLife
- The fitness costs of antibiotic resistance mutations
- (2014) Anita H. Melnyk et al. Evolutionary Applications
- Evolution of acquired resistance to anti-cancer therapy
- (2014) Jasmine Foo et al. JOURNAL OF THEORETICAL BIOLOGY
- Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
- (2014) Charlie G. Buffie et al. NATURE
- Targeting virulence: can we make evolution-proof drugs?
- (2014) Richard C. Allen et al. NATURE REVIEWS MICROBIOLOGY
- Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections
- (2014) P. Ankomah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The path of least resistance: aggressive or moderate treatment?
- (2014) R. D. Kouyos et al. PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Cancer Evolution: Mathematical Models and Computational Inference
- (2014) Niko Beerenwinkel et al. SYSTEMATIC BIOLOGY
- When the Most Potent Combination of Antibiotics Selects for the Greatest Bacterial Load: The Smile-Frown Transition
- (2014) Rafael Pena-Miller et al. PLOS BIOLOGY
- Limiting Damage during Infection: Lessons from Infection Tolerance for Novel Therapeutics
- (2014) Pedro F. Vale et al. PLOS BIOLOGY
- A Modeling Framework for the Evolution and Spread of Antibiotic Resistance: Literature Review and Model Categorization
- (2013) Ian H. Spicknall et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Comparison of the Respiratory Microbiome in Healthy Nonsmokers and Smokers
- (2013) Alison Morris et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Evolutionary foundations for cancer biology
- (2013) C. Athena Aktipis et al. Evolutionary Applications
- Anthracyclines Induce DNA Damage Response-Mediated Protection against Severe Sepsis
- (2013) Nuno Figueiredo et al. IMMUNITY
- Fecal Transplantation for RecurrentClostridium difficileInfection in Older Adults: A Review
- (2013) Kristin E. Burke et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resource Competition May Lead to Effective Treatment of Antibiotic Resistant Infections
- (2013) Antonio L. C. Gomes et al. PLoS One
- HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice
- (2013) J. A. Horwitz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Two Drugs Are Better than One--Modeling Drug Combinations in Cancer Therapy
- (2013) M. K. Callahan Science Translational Medicine
- Aggressive Chemotherapy and the Selection of Drug Resistant Pathogens
- (2013) Silvie Huijben et al. PLoS Pathogens
- Evolutionary dynamics of cancer in response to targeted combination therapy
- (2013) Ivana Bozic et al. eLife
- Cancer chemotherapy: A critical analysis of its 60 years of history
- (2012) Darío Galmarini et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- New Drugs for the Treatment of Tuberculosis: Needs, Challenges, Promise, and Prospects for the Future
- (2012) Christian Lienhardt et al. JOURNAL OF INFECTIOUS DISEASES
- Clonal evolution in cancer
- (2012) Mel Greaves et al. NATURE
- Antiretroviral dynamics determines HIV evolution and predicts therapy outcome
- (2012) Daniel I S Rosenbloom et al. NATURE MEDICINE
- “One-Size-Fits-All”? Optimizing Treatment Duration for Bacterial Infections
- (2012) Patricia Geli et al. PLoS One
- The evolution of plasmid-carried antibiotic resistance
- (2011) Fabian Svara et al. BMC EVOLUTIONARY BIOLOGY
- Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine
- (2011) E. Abbate et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Population biological principles of drug-resistance evolution in infectious diseases
- (2011) Pia Abel zur Wiesch et al. LANCET INFECTIOUS DISEASES
- Overlooking Evolution: A Systematic Analysis of Cancer Relapse and Therapeutic Resistance Research
- (2011) C. Athena Aktipis et al. PLoS One
- The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy
- (2011) A. F. Read et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tempo and mode of inhibitor-mutagen antiviral therapies: A multidisciplinary approach
- (2011) J. Iranzo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Optimization of Dosing for EGFR-Mutant Non-Small Cell Lung Cancer with Evolutionary Cancer Modeling
- (2011) J. Chmielecki et al. Science Translational Medicine
- Compensation of Fitness Costs and Reversibility of Antibiotic Resistance Mutations
- (2010) P. Schulz zur Wiesch et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A theoretical quantitative model for evolution of cancer chemotherapy resistance
- (2010) Ariosto S Silva et al. Biology Direct
- Antivirulence drugs to target bacterial secretion systems
- (2010) Christian Baron CURRENT OPINION IN MICROBIOLOGY
- The continuing crisis in antibiotic resistance
- (2010) G.L. French INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Anti-virulence strategies to combat bacteria-mediated disease
- (2010) David A. Rasko et al. NATURE REVIEWS DRUG DISCOVERY
- Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
- (2010) Jennifer S. Temel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Engineered bacterial communication prevents Vibrio cholerae virulence in an infant mouse model
- (2010) F. Duan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Optimal Drug Synergy in Antimicrobial Treatments
- (2010) Joseph Peter Torella et al. PLoS Computational Biology
- Tumor Growth Instability and Its Implications for Chemotherapy
- (2009) P. Castorina et al. CANCER RESEARCH
- Adaptive Therapy
- (2009) R. A. Gatenby et al. CANCER RESEARCH
- Antibiotic resistance—What’s dosing got to do with it?
- (2009) Jason A. Roberts et al. CRITICAL CARE MEDICINE
- A change of strategy in the war on cancer
- (2009) Robert A. Gatenby NATURE
- Cancer Cell Metabolism: Warburg and Beyond
- (2008) Peggy P. Hsu et al. CELL
- Acquired resistance to tyrosine kinase inhibitors during cancer therapy
- (2008) Jeffrey A Engelman et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Modelling chemotherapy resistance in palliation and failed cure
- (2008) Helen C. Monro et al. JOURNAL OF THEORETICAL BIOLOGY
- Exploring the role of the immune response in preventing antibiotic resistance
- (2008) Andreas Handel et al. JOURNAL OF THEORETICAL BIOLOGY
- The Impact of Different Antibiotic Regimens on the Emergence of Antimicrobial-Resistant Bacteria
- (2008) Erika M. C. D'Agata et al. PLoS One
- Accelerated evolution of resistance in multidrug environments
- (2008) M. Hegreness et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Cholesterol Biosynthesis Inhibitor Blocks Staphylococcus aureus Virulence
- (2008) C.-I Liu et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now